-
公开(公告)号:US11753386B2
公开(公告)日:2023-09-12
申请号:US17272031
申请日:2019-08-30
Applicant: Amgen, Inc.
Inventor: Sebastien Caille , Michael Corbett , Austin Smith
IPC: C07D263/14 , C07D211/76
CPC classification number: C07D263/14 , C07D211/76 , C07B2200/13
Abstract: The present invention provides commercial processes for preparing 2-((3R,5R,6S)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-1-((S)-1-(isopropylsulfonyl)-3-methylbutan-2-yl)-3-methyl-2-oxopiperidin-3-yl)acetic acid as well as intermediates thereof.
-
公开(公告)号:US20230379796A1
公开(公告)日:2023-11-23
申请号:US18363661
申请日:2023-08-01
Applicant: Amgen, Inc.
Inventor: Sebastien Caille , Michael Corbett , Austin Smith
Abstract: The present invention provides commercial processes for preparing 2-((3R,5R,6S)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-1-((S)-1-(isopropylsulfonyl)-3-methylbutan-2-yl)-3-methyl-2-oxopiperidin-3-yl)acetic acid as well as intermediates thereof.
-
公开(公告)号:US20210347743A1
公开(公告)日:2021-11-11
申请号:US17272031
申请日:2019-08-30
Applicant: Amgen, Inc.
Inventor: Sebastien Caille , Michael Corbett , Austin Smith
IPC: C07D263/14 , C07D211/76
Abstract: The present invention provides commercial processes for preparing 2-((3R,5R,6S)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-1-((S)-1-(isopropylsulfonyl)-3-methylbutan-2-yl)-3-methyl-2-oxopiperidin-3- yl)acetic acid as well as intermediates thereof.
-
-